首页|真武汤联合连续静-静脉血液透析滤过治疗脓毒症急性肾损伤患者的效果

真武汤联合连续静-静脉血液透析滤过治疗脓毒症急性肾损伤患者的效果

扫码查看
目的:观察真武汤联合连续静-静脉血液透析滤过(CVVHDF)治疗脓毒症急性肾损伤患者的效果.方法:选取 2020 年12 月至 2022 年 12 月汝州市人民医院收治的 82 例脓毒症急性肾损伤患者进行前瞻性研究,按照随机数字表法将其分为对照组和观察组各41 例.对照组给予CVVHDF治疗,观察组在对照组基础上联合真武汤治疗.比较两组临床疗效,预后指标[住重症监护病房(ICU)时间、尿量恢复时间、器官支持治疗时间]水平,治疗前后肾功能指标[血肌酐(Scr)、尿素氮(BUN)、胱抑素C(CysC)]水平、急性生理功能和慢性健康状况评分系统Ⅱ(APACHEⅡ)评分和T细胞亚群指标(CD3+、CD4+、CD4+/CD8+)水平.结果:观察组治疗总有效率为 92.68%(38/41),高于对照组的 70.73%(29/41),差异有统计学意义(P<0.05);观察组住ICU时间、尿量恢复时间、器官支持治疗时间均短于对照组,差异有统计学意义(P<0.05);两组Scr、BUN、CysC水平和APACHEⅡ评分均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05);两组CD3+、CD4+、CD4+/CD8+水平均高于治疗前,且观察组高于对照组,差异有统计学意义(P<0.05).结论:真武汤联合CVVHDF治疗脓毒症急性肾损伤患者可提高治疗总有效率和T细胞亚群指标水平,以及降低预后指标水平、肾功能指标水平和APACHEⅡ评分的效果优于单纯CVVHDF治疗效果.
Effects of Zhenwu decoction combined with continuous veno-venous hemodiafiltration in treatment of sepsis patients with acute renal injury
Objective:To observe effects of Zhenwu decoction combined with continuous veno-venous hemodiafiltration(CVVHDF)in treatment of sepsis patients with acute renal injury.Methods:A prospective study was conducted on 82 sepsis patients with acute renal injury admitted to Ruzhou People's Hospital from December 2020 to December 2022.They were divided into control group and observation group according to the random number table method,41 cases in each.The control group was treated with CVVHDF,while the observation group was treated with Zhenwu decoction on the basis of that of the control group.The clinical efficacy,the prognostic indicators(ICU stay time,urine volume recovery time,organ support treatment time)levels,the renal function indicators[serum creatinine(Scr),urea nitrogen(BUN),cystatin C(CysC)]levels before and after the treatment,the acute physiology and chronic health evaluation scoring system Ⅱ(APACHE Ⅱ)score,and the T cell subsets(CD3+,CD4+,CD4+/CD8+)levels were compared between the two groups.Results:The total effective rate of the observation group was 92.68%(38/41),which was higher than 70.73%(29/41)of the control group,and the difference was statistically significant(P<0.05).The ICU stay time,the urine volume recovery time and the organ support treatment time in the observation group were shorter than those in the control group,and the differences were statistically significant(P<0.05).The levels of Scr,BUN,CysC and APACHE Ⅱ scores in the two groups were lower than those before the treatment,those in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).Further,the levels of CD3+,CD4+and CD4+/CD8+in the two groups were higher than those before the treatment,those in the observation group were higher than those in the control group,and the differences were statistically significant(P<0.05).Conclusions:Zhenwu decoction combined with CVVHDF can improve the total effective rate of treatment and the levels of T cell subsets,and reduce the levels of prognostic indicators and renal function indicators and the APACHE Ⅱ scores in the sepsis patients with acute kidney injury.Moreover,it is superior to single CVVHDF.

SepsisAcute kidney injuryContinuous veno-venous hemodiafiltrationZhenwu decoctionRenal function

王辉、任俊涛、王文涛

展开 >

汝州市人民医院重症医学科,河南 平顶山 467599

郑州大学第二附属医院重症医学科,河南 郑州 450000

脓毒症 急性肾损伤 连续静-静脉血液透析滤过 真武汤 肾功能

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(12)
  • 10